Rentokil Initial PLC
27 July 2004
27th July 2004 - Embargoed until 0700 am
Rentokil Initial plc
James Wilde steps down as Chief Executive
James Wilde, Chief Executive of Rentokil Initial plc, is to leave the company
with immediate effect, by mutual consent. Whilst a new Chief Executive is being
sought, Brian McGowan, Chairman, will step into the role of Executive Chairman,
supported by the Finance Director and the four sector Managing Directors who
will continue to be responsible for the day to day management of the businesses.
Brian McGowan said 'The Board wishes James well. He initiated a number of much
needed changes and the Board is committed to continuing and indeed accelerating
the good work that he started.
'As announced at the Company's annual general meeting on 27th May, I continue to
lead the review of the business. It remains the Board's intention to present the
outcome of that review at the time of the company's interim results, which will
be announced, as planned, on 26th August. In the meantime we have no reason to
change the statement we made at the AGM regarding the outlook for the full
year.'
- Ends -
For further information, please contact:
Charles Grimaldi, Corporate Affairs Director 00 44 (0)1342 833022
Gill Ackers / Jonathan Rhodes, Brunswick Group
LLP 00 44 (0)20 7404 5959
07974 982382 / 07974 982334
Alex Mackey 07773 787458
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.